Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jennifer A. Otani-Rosa"'
Autor:
Jennifer A. Otani-Rosa, Ronnie W. Neuberg, Jeanne M. Meck, Jeffrey A. Welsh, Aurelia Meloni-Ehrig, Philip N. Mowrey
Publikováno v:
Cancer Genetics and Cytogenetics. 195:192-194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5e5311e14296455efcd3a3514a8756f
https://doi.org/10.1016/j.cancergencyto.2009.08.019
https://doi.org/10.1016/j.cancergencyto.2009.08.019
Autor:
Heather R. Sanders, Debra Boles, Zhong J Zhang, Christine R. Bryke, Philip N. Mowrey, Steven Schonberg, Albert K Ho, Dan Jones, Jennifer A. Otani-Rosa, Aurelia Meloni-Ehrig, Zunyan Dai, Nicole C. Christacos, Marilyn L. Slovak, JoAnn C. Kelly, Qiulu Pan
Publikováno v:
Molecular Cytogenetics
Molecular Cytogenetics, Vol 5, Iss 1, p 44 (2012)
Molecular Cytogenetics, Vol 5, Iss 1, p 44 (2012)
Background Anaplastic lymphoma receptor tyrosine kinase (ALK) gene rearrangements have been reported in 2-13% of patients with non-small cell lung cancer (NSCLC). Patients with ALK rearrangements do not respond to EGFR-specific tyrosine kinase inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f606bf1cda87598672ce3cc4fab31666
https://pubmed.ncbi.nlm.nih.gov/23198868
https://pubmed.ncbi.nlm.nih.gov/23198868
Autor:
Philip N. Mowrey, Jennifer A. Otani-Rosa, Dan Jones, Zunyan Dai, Ya-Hsuan Hsu, Jennifer Jahn, Marilyn L. Slovak, Marc A. Sanidad
Publikováno v:
Blood. 120:1444-1444
Abstract 1444 Objective: Risk-adapted therapeutic categories in acute lymphoblastic leukemia (ALL) take into account several key parameters, including cytogenetics. Because accurate conventional chromosome (CC) studies in ALL are hampered by low mito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0a84473cfb6060c7605bed90f1c4053
https://doi.org/10.1182/blood.v120.21.1444.1444
https://doi.org/10.1182/blood.v120.21.1444.1444